Purpose and Summary
H.R. 8535, the ``Measuring Illicit Fentanyl Trafficking
Act,'' would require the Secretary of Homeland Security to
develop performance metrics relating to the detection,
deterrence, and seizure of illicit fentanyl for the Department
of Homeland Security and each of its components. As illicit
fentanyl is the leading cause of overdose deaths in the United
States, this legislation would seek to bolster data sharing
across the Department and eliminate siloing of information that
could impair the Department's effectiveness in countering this
threat.
Background and Need for Legislation
Fentanyl deaths are the leading cause of overdose deaths in
the United States, killing tens of thousands of people, and the
leading cause of death overall for those ages 18-45. Nearly all
the precursors, or key ingredients, of illicit fentanyl are
produced in China and then shipped to Mexico where illicit
fentanyl is manufactured and smuggled into the United States.
Frontline officers and agents within the Department of Homeland
Security (DHS), specifically, U.S. Customs and Border
Protection (CBP) and Homeland Security Investigations (HSI)
within U.S. Immigration and Customs Enforcement (ICE), are the
entities primarily charged with detecting and seizing illicit
fentanyl. From Fiscal Year (FY) 2021 through FY 2024, CBP and
ICE led or assisted on the seizure of nearly 460,000 pounds of
fentanyl and fentanyl precursors.
While CBP and ICE are seizing fentanyl and fentanyl
precursors, DHS does not consider overdose death numbers, drug
street pricing, or other factors that could indicate the volume
at which fentanyl is still entering the country. In an effort
to address this problem, the James M. Inhofe National Defense
Authorization Act (NDAA) for Fiscal Year 2023 (P.L. 117-263)
required DHS to establish a program that would collect data and
develop measures to assess the effectiveness of efforts to
detect and deter illicit fentanyl. It also required the
Government Accountability Office (GAO) to conduct an audit of
the program.
In September 2025, the Government Accountability Office
(GAO) released their report evaluating DHS's implementation of
the program, as required by the FY 2023 NDAA. The report found
that DHS had not established the program as required by the
Act, that CBP was not provided information from across the
Department that would inform the program, and that DHS had not
developed performance goals or metrics to assess the program's
effectiveness.
This legislation would build on the efforts of the FY 2023
NDAA by requiring the Secretary of Homeland Security to develop
performance metrics relating to the detection, deterrence, and
seizure of illicit fentanyl, and to require each relevant
component of DHS to share information between components and
identify any barriers that would prevent the sharing of this
data. The legislation requires this to take place within one
year of enactment.
Hearings
The Committee held the following hearings in the 119th
Congress that informed H.R. 8535:
On March 5, 2025, the Committee on Homeland Security held a
hearing entitled ``Countering Threats Posed by the Chinese
Communist Party to U.S. National Security.'' Members received
testimony from Dr. Rush Doshi, Assistant Professor of Security
Studies at the Georgetown University Walsh School of Foreign
Service and C.V. Starr Senior Fellow for Asia Studies and
Director of the China Strategy Initiative at the Council on
Foreign Relations. In his testimony, Mr. Doshi highlighted the
role of the Chinese Communist Party in subsidizing the
manufacturing of fentanyl precursors and aiding cartels in
trafficking deadly fentanyl into the United States.
On January 22, 2026, the Subcommittee on Border Security
and Enforcement held a hearing entitled, ``Smarter Borders,
Safer Nation: Expanding the Use of Non-Intrusive Inspection
Technology.'' Members received testimony from Diane J.
Sabatino, Acting Executive Assistant Commissioner, Office of
Field Operations, U.S. Customs and Border Protection, U.S.
Department of Homeland Security. Ms. Sabatino testified to the
importance of non-intrusive inspection technology in seizing
illicit drugs, including fentanyl.
Committee Consideration
The Committee met on June 24, 2026, a quorum being present,
to consider H.R. 8535 and ordered the measure to be favorably
reported to the House, as amended, by a recorded vote of 30
yeas to 0 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
recorded votes on the motion to report legislation and the
amendments thereto. The following reflects the recorded votes
taken during the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
COMMITTEE OVERSIGHT FINDINGS
In compliance with clause 3(c)(1) of rule XIII, the
Committee advises that the findings and recommendations of the
Committee, based on oversight activities under clause 2(b)(1)
of rule X, are incorporated in the descriptive portions of this
report.
CONGRESSIONAL BUDGET OFFICE ESTIMATE, NEW BUDGET AUTHORITY, ENTITLEMENT
AUTHORITY, AND TAX EXPENDITURES
With respect to the requirements of clause 3(c)(2) of rule
XIII and section 308(a) of the Congressional Budget Act of
1974, and with respect to the requirements of clause 3(c)(3) of
rule XIII and section 402 of the Congressional Budget Act of
1974, the Committee has requested but not received from the
Director of the Congressional Budget Office a statement as to
whether this bill contains any new budget authority, spending
authority, credit authority, or an increase or decrease in
revenues or tax expenditures.
FEDERAL MANDATES STATEMENT
An estimate of Federal mandates prepared by the Director of
the Congressional Budget Office pursuant to section 423 of the
Unfunded Mandates Reform Act was not made available to the
Committee in time for the filing of this report. The Chairman
of the Committee shall cause such estimate to be printed in the
Congressional Record upon its receipt by the Committee.
DUPLICATIVE FEDERAL PROGRAMS
Pursuant to clause 3(c) of rule XIII, the Committee finds
that H.R. 8535 does not contain any provision that establishes
or reauthorizes a program known to be duplicative of another
Federal program.
STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES
Pursuant to clause 3(c)(4) of rule XIII, the objective of
H.R. 8535 is to require the Secretary of Homeland Security to
develop performance metrics relating to the detection,
deterrence, and seizure of illicit fentanyl for the Department
of Homeland Security and its components. The bill also requires
each relevant component of the Department to share information
related to the detection, deterrence, and seizure of illicit
fentanyl and identify any barrier related to the sharing of
this information and data.
CONGRESSIONAL EARMARKS, LIMITED TAX BENEFITS,
AND LIMITED TARIFF BENEFITS
In compliance with rule XXI, this bill, as reported,
contains no congressional earmarks, limited tax benefits, or
limited tariff benefits as defined in clause 9(d), 9(e), or
9(f) of rule XXI.
ADVISORY COMMITTEE STATEMENT
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
APPLICABILITY TO THE LEGISLATIVE BRANCH
The Committee finds that H.R. 8535 does not relate to the
terms and conditions of employment or access to public services
or accommodations within the meaning of section 102(b)(3) of
the Congressional Accountability Act.
SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION
Section 1. Short title
This section states that the Act may be cited as the
``Measuring Illicit Fentanyl Trafficking Act.''
Section 2. Combatting illicit fentanyl
This section requires the Secretary of Homeland Security,
not later than one year after the date of enactment of this
legislation, to ensure that each component of DHS which is
engaged in the detection, deterrence, and seizure of illicit
fentanyl, collaborate and share, to the extent practicable,
information and data regarding the detection, deterrence, and
seizure of illicit fentanyl with other DHS components engaged
in these activities. It also requires each DHS component
engaged in combatting illicit fentanyl trafficking to identify
any barriers to sharing the relevant information and data.
This section also requires the Secretary to develop
performance measures relating to the detection, deterrence, and
seizure of illicit fentanyl for DHS and each DHS component, and
ensure that the metrics align with the strategic goals of the
Department as it relates to combatting illicit fentanyl
trafficking.
[all]